Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats

BACKGROUND/AIMS: Non-alcoholic fatty liver disease is associated with insulin resistance. Compound K (CK) is the final metabolite of panaxadiol ginsenosides that have been shown to exert antidiabetic effects. However, the molecular mechanism of the antidiabetic effects in the liver have not been elu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Intern Med
Main Authors: Hwang, Yoo-Cheol, Oh, Da-Hee, Choi, Moon Chan, Lee, Sang Yeoul, Ahn, Kyu-Jeong, Chung, Ho-Yeon, Lim, Sung-Jig, Chung, Sung Hyun, Jeong, In-Kyung
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5840580/
https://ncbi.nlm.nih.gov/pubmed/28142230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2015.208
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados